Malini Olivo | |
---|---|
![]() | |
Alma mater | |
Scientific career | |
Fields | Biophotonics, Medtech, Nano-biophotonics |
Institutions |
Malini Olivo is the Distinguished Principal Scientist of A*STAR Skin Research Labs (A*SRL) where she spearheads the Translational Biophotonics Laboratory. Concurrently, she is also an adjunct professor at the Department of Obstetrics & Gynaecology, National University Health System, NUS, Singapore; and Royal College of Surgeons Ireland, Dublin, Ireland. In 2015, she was elected by the Optical Society of America for "pioneering contribution in clinical photodiagnostics in the area of clinical spectroscopy and imaging in early cancer detection and photo-therapeutics of cancer". [1] [2]
She obtained a Bachelor of Science with Education degree in Physics and Mathematics in 1985 and a Doctorate degree in Biomedical Physics from the University of Malaya and University College London (UCL) in 1991, working on photodynamic therapy of cancer. Following her doctorate, she honed her expertise in medical biophotonics by doing her post-doctoral training from 1991 to 1995, collaborating with top-notch institutions such as UCL in the UK, McMaster University and the University of Toronto.
She is currently a Senior Principal Investigator and Distinguished Principal Scientist in A*SRL, a research institute of the Agency for Science, Technology and Research (A*STAR). [3] She was previously appointed as Senior Scientist and Principal Investigator at National Cancer Centre Singapore between 1995 and 2009. In 2007, she was also appointed as Head of Bio-optical Imaging at the Singapore Bioimaging Consortium (SBIC) and also adjunct professor at Department of Pharmacy, National University of Singapore. In 2009, she was appointed as Stokes Professor of Biophotonics at the National University of Ireland, Galway and Adjunct Professor of Biophotonics in Royal College of Surgeons in Ireland.
She is recognised for her research in photomedicine by the International Biophotonics Community and regarded as a pioneer in the area of clinical applications of photomedicine in optical diagnostics and therapeutics both in Singapore and Ireland.
She received the SingHealth research excellence award for her contribution to scientific research excellence in the area of clinical biophotonics for diagnostics and therapeutics of cancer. She has won numerous awards in recognition of her contribution to biophotonics in Singapore, Ireland and the United States, including election as a fellow of the American Institute for Medical and Biological Engineering [4] and Fellow of the Optical Society of America in 2015. She has successfully secured over 25 million USD in competitive research funding to support her pioneering work in Singapore and internationally. She has authored more than 500 scientific papers, holds a H-index of 62, and has been granted over more than 60 patents. In addition to that, she also published three books, and 20 chapters in her name.
She has proven to be a highly prolific inventor, with nearly 60 patented technology platforms and devices that could significantly impact the fields of healthcare and biophotonics. Additionally, she plays a crucial role as a co-founder in three innovative Medtech companies. Her international standing in her field allows her to serve in numerous international scientific advisory boards in the area of Photonics in Medicine.
Naomi J. Halas is the Stanley C. Moore Professor in Electrical and Computer Engineering, and professor of biomedical engineering, chemistry, and physics at Rice University. She is also the founding director of Rice University Laboratory for Nanophotonics, and the Smalley-Curl Institute. She invented the first nanoparticle with tunable plasmonic resonances, which are controlled by their shape and structure, and has won numerous awards for her pioneering work in the field of nanophotonics and plasmonics. She was also part of a team that developed the first dark pulse soliton in 1987 while working for IBM.
Bruce J. Tromberg is an American photochemist and a leading researcher in the field of biophotonics. He is the director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the National Institutes of Health (NIH). Before joining NIH, he was Professor of Biomedical Engineering at The Henry Samueli School of Engineering and of Surgery at the School of Medicine, University of California, Irvine. He was the principal investigator of the Laser Microbeam and Medical Program (LAMMP), and the Director of the Beckman Laser Institute and Medical Clinic at Irvine. He was a co-leader of the Onco-imaging and Biotechnology Program of the NCI Chao Family Comprehensive Cancer Center at Irvine.
Satoshi Kawata is a scientist based in Japan who is active in nanotechnology, photonics, plasmonics, and other areas of applied physics. He is a Professor of Department of Applied Physics at Osaka University. He is also a Chief Scientist at RIKEN. Kawata was the 2022 president of Optica.
Tia Emmetine Keyes is a professor of physical chemistry at the School of Chemical Sciences, and a member of the National Centre for Sensor Research at Dublin City University.
William Douglas Figg is an American scientist (pharmacologist). He is a senior investigator (tenured) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland. He holds multiple titles within the NCI: Associate Director of the Center for Cancer Research, Co-Director of the Office of Translational Resources, Acting Branch Chief for the Genitourinary Malignancies Branch, Chief of the Clinical Pharmacology Program, and head of the Molecular Pharmacology Section. Figg is also the Co-chief of Basic Research at the Center for Prostate Disease Research within the Walter Reed National Military Medical Center – Murtha Cancer Center in Bethesda, Maryland.
(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.
Elizabeth Ruth Plummer is a Professor of Experimental Cancer Medicine at Newcastle University and an oncologist specialising in treating patients with melanoma. Based in Newcastle, she directs the Sir Bobby Robson Cancer Trials Research Centre, set up by the Sir Bobby Robson Foundation to run early-stage clinical trials.v Plummer and the Newcastle team won a 2010 Translational Cancer Research Prize from Cancer Research UK for work using rucaparib to treat ovarian cancer. Plummer was elected as a fellow of the UK's Academy of Medical Sciences in 2018.
Anita Mahadevan-Jansen is a Professor of Biomedical Engineering and holds the Orrin H. Ingram Chair in Biomedical Engineering at Vanderbilt University. Her research considers the development of optical techniques for clinical diagnosis and surgical guidance, particularly using Raman and fluorescence spectroscopy. She serves on the Board of Directors of SPIE, and is a Fellow of SPIE, The Optical Society, Society for Applied Spectroscopy, and the American Society for Lasers in Medicine and Surgery. She was elected to serve as the 2020 Vice President of SPIE. With her election, Mahadevan-Jansen joined the SPIE presidential chain and served as President-Elect in 2021 and the Society's President in 2022.
Laura Marcu is an American scientist and a professor of biomedical engineering and neurological surgery at the University of California, Davis. She is also a Fellow of numerous professional societies: the Biomedical Engineering Society, SPIE, The Optical Society and the National Academy of Inventors.
Nirmala (Nimmi) Ramanujam is an educator, innovator, and entrepreneur. Ramanujam is recognized for creating globally accessible technologies for women’s health related to cancer screening, diagnosis, and treatment. She is the Robert W. Carr Professor of Engineering and Professor of Cancer Pharmacology and Global Health at Duke University. She founded the Center for Global Women’s Health Technologies in 2013 to catalyze impactful research, educational and community outreach activities that promote women’s health. In 2023, she won the IEEE Biomedical Engineering Technical Field Award, given annually for outstanding contributions to the field of Biomedical engineering. In 2019, she received the social impact Abie Award for making a positive impact on women, technology, and society. She was elected as a fellow of the National Academy of Inventors in 2017. She founded Calla Health to commercialize technologies developed at the center. Further she has created a number of initiatives and consortia including WISH, (In)visible Organ and IGNITE to have far reaching impact in cervical cancer, reproductive health and engineering design education, respectively.
Audrey K. Ellerbee Bowden is an American engineer and Dorothy J. Wingfield Phillips Chancellor's Faculty Fellow at Vanderbilt University, as well as an Associate Professor of Biomedical Engineering and Electrical Engineering. She is a Fellow of Optica, the American Institute for Medical and Biological Engineering and the International Society for Optics and Photonics (SPIE).
Scott A. Waldman is an MD and biomedical scientist at Sidney Kimmel Medical College of Thomas Jefferson University, where he is the Samuel M.V. Hamilton Professor of Medicine, and also tenured professor and chair of the Department of Pharmacology & Experimental Therapeutics. He is author of a pharmacology textbook, and former chief editor of Clinical Pharmacology & Therapeutics. He is known for his work in atrial natriuretic factor intracellular signaling through guanylate cyclase (GC), and the relation of Guanylyl cyclase C (GC-C) to the pathogenesis of colorectal cancer. Also for his hypotheses concerning the roles of intestinal paracrine hormones in satiety, obesity and cancer risk. Waldman also holds a concurrent position as adjunct professor at the University of Delaware, School of Health Sciences.
Rosandra N. Kaplan is an American pediatric oncologist and scientist specialized in translational and clinical research on the mechanisms of cancer spread and the role of the tumor microenvironment in cancer progression. She is a principal investigator and head of the tumor microenvironment and metastasis branch at the National Cancer Institute.
Stefan Andersson-Engels is a Swedish biophysicist specializing in the field of biophotonics. He is professor at University College Cork and the deputy director of the Irish Photonics Integration Center (IPIC) within the Science Foundation Ireland. Before joining University College Cork, he was Professor of Biomedical Engineering at Lund University. He has co-founded 3 biophotonics companies Spectracure, Lumito, BioPixS. He also co-founded biannual biophotonics summer school.
Irene Georgakoudi is a Greek biophysicist and Professor of Biomedical Engineering at Tufts University, where her work focuses on developing non-invasive medical imaging techniques based on optical spectroscopy for applications in medical diagnostics and therapeutics.
Katarina Svanberg is a Swedish physician who is Professor and Chief Consultant of Oncology at the Skåne University Hospital. Her research considers the use of fluorescence-based tumour imaging and photodynamic therapy. She served as President of SPIE in 2011 and was awarded the SPIE Gold Medal in 2017.
Arjun Gaurang Yodh is an American physicist. He is the James M. Skinner Professor of Science at the University of Pennsylvania and former Director of the Laboratory for Research on the Structure of Matter.
Elizabeth Sally Ward is a British physician who is Director of Translational Immunology at the Centre for Cancer Immunology in the University of Southampton. She was elected Fellow of the Royal Society in 2022.
Igor Meglinski is a British, New Zealand and Finnish scientist serving as a principal investigator at the College of Engineering & Physical Sciences at Aston University, where he is a Professor in Quantum Biophotonics and Biomedical Engineering. He is a Faculty member in the School of Engineering and Technology at the Department of Mechanical, Biomedical & Design Engineering, and is also associated with the Aston Institute of Photonic Technologies (AIPT) and Aston Research Centre for Health in Ageing (ARCHA).
Ji-Xin Cheng is an academic, inventor, and entrepreneur. He holds the Moustakas Chair Professorship in Optoelectronics and Photonics at Boston University. His inventions span optical imaging, cancer diagnosis, neuromodulation, and phototherapy of infectious diseases. He holds positions of co-founder of Vibronic and of Pulsethera. He is also the scientific advisor of Photothermal Spectroscopy and Axorus.